Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 17/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 13/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4518038 | 1.00 | SLC6A3 (0.45) | SLC6A3SLC6A4SLC6A2LGALS3 | |
| SCHEMBL4518041 | 1.00 | SLC6A3 (0.45) | SLC6A3SLC6A4SLC6A2LGALS3 | |
| SCHEMBL4522740 | 0.83 | SLC6A3 (0.44) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4530086 | 0.83 | SLC6A3 (0.44) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4522742 | 0.83 | SLC6A3 (0.44) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4140307 | 0.83 | SLC6A3 (0.64) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4137511 | 0.83 | SLC6A3 (0.64) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4137508 | 0.83 | SLC6A3 (0.64) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4528618 | 0.82 | SLC6A3 (0.45) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4527916 | 0.82 | SLC6A3 (0.45) | SLC6A3SLC6A4SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7476740-B2 | Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-01-13 | — | — | US | disclosed |